V-Square Quantitative Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.41M Buy
29,602
+1,426
+5% +$200K 0.41% 32
2026
Q2
$3.56M Sell
28,176
-1,259
-4% -$166K 0.34% 39
2026
Q1
$4.1M Buy
29,435
+1,155
+4% +$162K 0.43% 27
2025
Q4
$3.47M Sell
28,280
-2,771
-9% -$337K 0.36% 34
2025
Q3
$3.45M Buy
31,051
+1,492
+5% +$170K 0.58% 31
2025
Q2
$3.28M Buy
29,559
+560
+2% +$59.6K 0.44% 34
2025
Q1
$3.25M Buy
28,999
+203
+0.7% +$20.9K 0.47% 33
2024
Q4
$2.66M Buy
28,796
+1,622
+6% +$146K 0.38% 42
2024
Q3
$2.28M Buy
27,174
+446
+2% +$34K 0.33% 49
2024
Q2
$1.83M Buy
26,728
+891
+3% +$59.5K 0.3% 52
2024
Q1
$1.89M Buy
25,837
+5,072
+24% +$390K 0.26% 54
2023
Q4
$1.68M Buy
20,765
+9,986
+93% +$777K 0.3% 43
2023
Q3
$808K Buy
10,779
+3,076
+40% +$237K 0.36% 51
2023
Q2
$594K Sell
7,703
-95
-1% -$7.58K 0.43% 48
2023
Q1
$647K Buy
+7,798
New +$646K 0.6% 41

Other funds holding GILD

V-Square Quantitative Management's GILD Position: Q3 2026 in Review

V-Square Quantitative Management increased its Gilead Sciences (GILD) stake by 5.1% in Q3 2026, buying an estimated $200K and bringing the position to 29,602 shares worth $4.41M. The position accounts for 0.41% of the portfolio, ranked #32.

V-Square Quantitative Management first reported a position in GILD in Q1 2023 and has held it in 15 quarters since. 1,384 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • V-Square Quantitative Management held 29,602 shares of Gilead Sciences worth $4.41M as of Q3 2026.
  • V-Square Quantitative Management bought 1,426 Gilead Sciences shares in Q3 2026, an estimated $200K.
  • Gilead Sciences made up 0.41% of V-Square Quantitative Management's portfolio in Q3 2026, its #32 holding.
  • V-Square Quantitative Management first reported a position in Gilead Sciences in Q1 2023 and has held it in 15 quarters since.
  • 1,384 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.